Business News • MarketWire • WeedMD Rx Inc. and Aumento Capital V Corporation Announces Closing of WeedMD Financing & Go-Public Transaction |
WeedMD Rx Inc. and Aumento Capital V Corporation Announces Closing of WeedMD Financing & Go-Public Transaction |
|
|
WeedMD Rx Inc. and Aumento Capital V Corporation Announces Closing of WeedMD Financing & Go-Public Transaction
TORONTO, ONTARIO--(Marketwired - Nov. 11, 2016) - WeedMD Rx Inc., ("WeedMD"), a licensed producer of medical marijuana under the Access to Cannabis for Medical Purposes Regulations, and Aumento Capital V Corporation (TSX VENTURE:AMN.P) ("Aumento") are pleased to announce that on November 9, 2016, WeedMD closed a $7,600,000 convertible debenture unit financing (the "Convertible Debenture Financing") with a syndicate of agents led by Dundee Securities Ltd., and including Canaccord Genuity Corp. and Echelon Wealth Partners Inc. (the "Agents"). Pursuant to the Convertible Debenture Financing, WeedMD has issued 7,600 units (the "Units"), with each Unit comprised of one debenture (a "Debenture") with a principal amount of $1,000 and 1,333 warrants (the "Warrants"). The Warrants are exercisable into common shares of WeedMD at an exercise price of $1.00 per share for a period of two years from the completion of a liquidity event by WeedMD. Immediately prior to completion of a liquidity event by WeedMD, the principal amount of the Debentures will be automatically convertible into common shares of WeedMD at a conversion price of $0.75 per share.
View More : http://www.marketwired.com/mw/release.do?id=2174941&sourceType=3
|
|
|